Cancer vaccines: comprehensive review
BJS Open · 12.05.2026 · 10 (3)
DOI: 10.1093/bjsopen/zrag041 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BJS Open, online erschienen am 29.05.2026. Verfasst von Rachael E Clifford und 13 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal and Peritoneal Oncology Centre (CPOC), The Christie NHS Foundation Trust, Manchester, UK. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
There has been an increasing focus on the potential of cancer vaccines as a therapeutic oncological option, aiming to harness the immune system to recognize and eliminate malignant cells. Unlike traditional therapies, vaccines exploit tumour-associated antigens and neoantigens to generate durable, tumour-specific immune responses.
Methods
This review provides a comprehensive overview of current vaccine strategies, their clinical applications, and implications for surgical oncology.
Results
Clinical trials highlight promising results in high-mutational burden cancers such as melanoma, lung, and bladder cancer, as well as in traditionally ‘cold’ tumours like pancreatic cancer. Combination strategies, particularly with checkpoint inhibitors, have shown enhanced efficacy, exemplified by messenger RNA-4157/V940 and autogene cevumeran in adjuvant settings. Off-the-shelf tumour-associated antigen vaccines offer scalability but face challenges of tolerance and limited specificity. Early data suggest vaccines may improve relapse-free survival and induce antigen spreading, broadening immune responses beyond the initial targets.
Conclusion
Cancer vaccines are poised to complement surgery and systemic therapies, particularly in the perioperative window. Their integration into multimodal treatment strategies may redefine precision oncology, offering durable disease control and improved patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Colorectal and Peritoneal Oncology Centre (CPOC), The Christie NHS Foundation Trust, Manchester, UK.
- The Liverpool Head and Neck Centre, The University of Liverpool, Liverpool, UK.
- Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York, New York, USA.
- Centre for Immuno-Oncology, University of Oxford, Oxford, UK.
- Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
ORCID-Profile: Rachael E Clifford, Sarah Danson
Förderung
- NCI NIH HHS
Zitieren
APA
Clifford, R. E., Manu, N., Yang, Q., Arif, Z., Aggen, D., Bryan, M. E., Gupta, A., Shaw, H., Church, D., Corrie, P., Savelyeva, N., Ottensmeier, C., Danson, S., & Jones, R. (2026). Cancer vaccines: comprehensive review. BJS Open, 10(3). https://doi.org/10.1093/bjsopen/zrag041
Vancouver
Clifford RE, Manu N, Yang Q, Arif Z, Aggen D, Bryan ME, et al. Cancer vaccines: comprehensive review. BJS Open. 2026;10(3). doi:10.1093/bjsopen/zrag041
BibTeX
@article{Clifford2026,
author = {Clifford, Rachael E and Manu, Nichola and Yang, Qian and Arif, Zeeshan and Aggen, David and Bryan, Michael E and Gupta, Aditi and Shaw, Heather and Church, David and Corrie, Philippa and Savelyeva, Natalia and Ottensmeier, Christian and Danson, Sarah and Jones, Robert},
title = {Cancer vaccines: comprehensive review},
journal = {BJS Open},
year = {2026},
volume = {10},
number = {3},
doi = {10.1093/bjsopen/zrag041}
}
EUVIMED